Pacmilimab (Anti-B7-H1 / PD-L1 / CD274)

Synonyms: CX-072

Pacmilimab (anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the tumor-associated antigen (TAA) programmed cell death 1 ligand 1 (PD-L1; B7-H1; CD274) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 152.6 kD.

Pacmilimab (Anti-B7-H1 / PD-L1 / CD274)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Pacmilimab (anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the tumor-associated antigen (TAA) programmed cell death 1 ligand 1 (PD-L1; B7-H1; CD274) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 152.6 kD.

Product Details

CAS No. 2145091-51-4
Molecular Weight 152.6
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) | Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) supplier | purchase Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) | Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) cost | Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) manufacturer | order Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) | Pacmilimab (Anti-B7-H1 / PD-L1 / CD274) distributor